Polarean Imaging plc (PLLWF)

Market Cap	n/a
Revenue (ttm)	2.56M +37.3%
Net Income	-9.60M
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	768,773
Open	0.0066
Previous Close	0.0010
Day's Range	0.0066 - 0.0066
52-Week Range	0.0010 - 0.0210
Beta	0.21
RSI	27.94
Earnings Date	Dec 24, 2025

About Polarean Imaging

Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 26
• Stock Exchange: OTCMKTS
• Ticker Symbol: PLLWF

Financial Performance

In 2024, Polarean Imaging's revenue was $3.09 million, an increase of 246.82% compared to the previous year's $890,933. Losses were -$8.54 million, -28.14% less than in 2023.